Related Experiment Video
Updated: Mar 13, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Management of anemia in patients with congestive heart failure
Lawrence Tim Goodnough1, Josep Comin-Colet2, Santiago Leal-Noval3
1Department of Pathology and Medicine, Stanford University, Stanford, California.
Insights
Anemia is common in congestive heart failure (CHF) patients and impacts outcomes. Managing anemia, particularly with intravenous iron, improves heart function, exercise tolerance, and quality of life, proving cost-effective.
Area of Science:
- Hematology
- Cardiology
- Clinical Outcomes
Background:
- Anemia is a significant independent risk factor for adverse patient outcomes.
- Anemia is highly prevalent in patients with congestive heart failure (CHF).
- Current guidelines for managing anemia in CHF patients are lacking.
Purpose of the Study:
- To determine the prevalence of anemia in outpatients and hospital-acquired anemia.
- To assess the impact of anemia management on quality of life and functional status.
- To provide recommendations for diagnosing, evaluating, and managing anemia in CHF patients.
Main Methods:
- Defined objectives through the International Anemia Management and Clinical Outcomes Expert Panel (AMCO).
- Reviewed prevalence data for anemia and iron deficiency in CHF patients.
- Evaluated the effects of anemia management strategies, including intravenous iron therapy.
Main Results:
- Anemia and iron deficiency are highly prevalent in CHF patients.
- Intravenous iron therapy improved anemia, cardiac function, and exercise tolerance.
- Anemia management was found to be cost-effective.
Conclusions:
- Anemia management in CHF patients significantly improves quality of life and functional status.
- Clinical care pathways for anemia management in CHF are recommended as best practices.
- Addressing anemia in CHF is crucial for improving patient outcomes.
Abstract:
Anemia is an independent risk factor for adverse patient outcomes. There are no guidelines for management of anemia in patients with congestive heart failure (CHF), despite its high incidence. Four objectives were defined by the International Anemia Management and Clinical Outcomes Expert Panel (AMCO), a multinational group of interdisciplinary experts identified by the Society for the Advancement of Blood Management (SABM) to: determine the prevalence of anemia in outpatients; to determine the prevalence of hospital-acquired anemia; to assess the impact of anemia management on clinical outcomes such as quality of life and functional status; and to provide recommendations for primary care physicians and specialists for the diagnosis, evaluation, and management of anemia in patients with CHF. Anemia and iron deficiency were confirmed to be highly prevalent in patients with CHF. Intravenous iron therapy improves anemia, cardiac function and exercise tolerance, leading to improvement in quality of life. Anemia management has been demonstrated to be cost-effective. Clinical care pathways to manage anemia in patients with CHF are recommended as best practices in order to improve patient outcomes. Am. J. Hematol. 92:88-93, 2017. © 2016 Wiley Periodicals, Inc.
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure VII: Nursing Interventions
Heart Failure VI: Adjunct Therapies
Cardiomyopathy VI: Nursing Management
Mitral Regurgitation IV: Nursing Management
Heart Failure IV: Classification and Diagnostic Evaluation

